Literature DB >> 26560514

Recent updates in chronic obstructive pulmonary disease.

Christine Garvey1.   

Abstract

Chronic obstructive pulmonary disease (COPD), characterized by chronic airways inflammation and progressive airflow limitation, is a common, preventable and treatable disease. Worldwide, COPD is a major cause of morbidity and mortality; smoking tobacco is the most important risk factor. This translational review of recent updates in COPD care for the primary care audience, includes recommendations from the 2015 Global Initiative for chronic obstructive lung disease (GOLD) report on diagnosis, pharmacological and non-pharmacological treatment, prevalence of comorbidities, management of exacerbations and the asthma and COPD overlap syndrome, with a focus on the importance and benefit of physical activity and exercise in COPD patients. Exacerbations and comorbidities contribute to the overall severity of COPD in individual patients. Management of exacerbations includes reducing the impact of the current exacerbation and preventing development of subsequent episodes. Healthcare professionals need to be alert to comorbidities, such as cardiovascular disease, anxiety/depression, lung cancer, infections and diabetes, which are common in COPD patients and can have a significant impact on HRQoL and prognosis. Pulmonary rehabilitation is recommended by a number of guidelines for all symptomatic COPD patients, regardless of severity, and involves exercise training, patient education, nutritional advice and psychosocial support. At all stages of COPD, regular physical activity and exercise can aid symptom control, improve HRQoL, reduce rates of hospitalization, and improve morbidity and respiratory mortality. Healthcare professionals play a pivotal role in improving HRQoL and health-related outcomes in COPD patients to meet their specific needs and in providing appropriate diagnosis, management and advice on smoking cessation.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; comorbidities; exacerbations; exercise; physical activity; smoking cessation

Mesh:

Year:  2015        PMID: 26560514     DOI: 10.1080/00325481.2016.1118352

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  10 in total

1.  Using Hyperpolarized Xenon-129 MRI to Quantify Early-Stage Lung Disease in Smokers.

Authors:  Kai Ruppert; Kun Qing; James T Patrie; Talissa A Altes; John P Mugler
Journal:  Acad Radiol       Date:  2018-12-03       Impact factor: 3.173

Review 2.  Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Juan Shi; Feng Li; Meihui Luo; Jun Wei; Xiaoming Liu
Journal:  Mediators Inflamm       Date:  2017-05-09       Impact factor: 4.711

3.  How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case-Finding Method for Spanish-Speaking Patients.

Authors:  Wilson A Quezada; Beth A Whippo; Patricia A Jellen; Nancy K Leidy; David M Mannino; Katherine J Kim; MeiLan K Han; Julia F Houfek; Barry Make; Karen G Malley; Catherine A Meldrum; Stephen I Rennard; Barbara P Yawn; Fernando J Martinez; Byron M Thomashow
Journal:  Chest       Date:  2017-04-14       Impact factor: 9.410

Review 4.  A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.

Authors:  Peter G Shields; Micah Berman; Theodore M Brasky; Jo L Freudenheim; Ewy Mathe; Joseph P McElroy; Min-Ae Song; Mark D Wewers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-22       Impact factor: 4.254

5.  Pathophysiological mechanism of long-term noninvasive ventilation in stable hypercapnic patients with COPD using functional respiratory imaging.

Authors:  Bita Hajian; Jan De Backer; Claire Sneyers; Francisca Ferreira; Katherine C Barboza; Glenn Leemans; Wim Vos; Wilfried De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-28

6.  Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.

Authors:  Samantha J Thulborn; Madiha Dilpazir; Koirobi Haldar; Vijay Mistry; Christopher E Brightling; Michael R Barer; Mona Bafadhel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-18

7.  Jian-Pi-Yi-Fei granule suppresses airway inflammation in mice induced by cigarette smoke condensate and lipopolysaccharide.

Authors:  Cui-Ying Tang; Si-Li Tang; Kai-Feng Huang; Jian Xu; Hui Yu; Lin Lin
Journal:  Indian J Pharmacol       Date:  2019 Jul-Aug       Impact factor: 1.200

8.  Analysis of viral infection and biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Tiping Yin; Zhaoqin Zhu; Zhoufang Mei; Jingjing Feng; Wanju Zhang; Yanchao He; Jindong Shi; Ling Qian; Yi Liu; Qihui Huang; Yunwen Hu; Zhijun Jie
Journal:  Clin Respir J       Date:  2017-06-15       Impact factor: 2.570

9.  Exercise Training Mitigates Water Pipe Smoke Exposure-Induced Pulmonary Impairment via Inhibiting NF-κB and Activating Nrf2 Signalling Pathways.

Authors:  Abderrahim Nemmar; Suhail Al-Salam; Priya Yuvaraju; Sumaya Beegam; Badreldin H Ali
Journal:  Oxid Med Cell Longev       Date:  2018-03-06       Impact factor: 6.543

10.  Towards a better understanding of physical activity in people with COPD: predicting physical activity after pulmonary rehabilitation using an integrative competence model.

Authors:  Johannes Alexander Carl; Wolfgang Geidl; Michael Schuler; Eriselda Mino; Nicola Lehbert; Michael Wittmann; Konrad Schultz; Klaus Pfeifer
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 2.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.